http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0331264-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0931241d9441d023245580a92141bf68
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1989-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64c66cdb7069fcfe3d2bfc6dcd35c14a
publicationDate 1991-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0331264-A
titleOfInvention Benzimidazole derivatives
abstract NEW MATERIAL:Compounds of formula 1 (R 1 and R 2 are H, lower alkyl or halogen; R 3 is lower alkyl, phenyl which may have lower alkyl as substituent, halogen-substituted lower alkyl, amino, lower alkylamino or lower alkanoylamino; R 4 is H, lower alkyl, nitro or amino; R 5 is H, hydroxyl or benzyloxy; R 6 is H or lower alkyl; n is 0 or 1) or salts thereof. n EXAMPLE: 1-(3,5-Di-tert-butyl-4-hydroxyphenyl)-2-trifluoromethylbenzimidazole. n USE: Useful as an antibacterial agent, an antiviral agent, an anti-inflammatory agent, an antirheumatic, etc. n PREPARATION: For example, a compound of formula 2 is condensed with a compound of formula 3 in the presence of a catalyst and the resultant compound of formula 4 is reduced by the conventional method to obtain a compound of formula 5. The obtained compound of formula 5 is reacted with a compound of formula R 3a -COOH [R 3a is (halogenated)alkyl] and subjected to cyclization, thus obtaining the objective compound of formula 1 in which R 3 is R 3a , R 5 is OH; n=0. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7635774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7285551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-653816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0694535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0520200-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0520200-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008019030-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008303211-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6770666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7112600-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008019030-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004000817-A3
priorityDate 1989-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88514056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235145924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 43.